FRENCH GLENDON E. III (President and CEO) sold 3.5% of their position (41.88K shares) of PULMONX CORP on the open market
Open‑market sale worth $94.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/3/2026ACC: 0001805624-26-000004
DirectorOfficer· President and CEO
Since Sep 2020
-41.88K
Net shares
Net seller
$94.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
41.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.10K
Price / share
$2.26
Trade value
$9.26K
% of position
0.3%
9/1/2026
1.18M→1.18M
Common Stock
Direct
Shares
−37.78K
Price / share
$2.26
Trade value
$85.39K
% of position
3.2%
9/1/2026
1.18M→1.14M
Total
Net shares
−41.88K
Net value
-$94.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −4.10K | $2.26 | $9.26K | 0.3% | 1.18M | 1.18M |
| Common Stock Direct | 9/1/2026 | S · Sale | −37.78K | $2.26 | $85.39K | 3.2% | 1.18M | 1.14M |
| Total | −41.88K | -$94.65K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned918.20K
Total
918.20K indirect918.20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 918.20K | Indirect |
| Total | 918.20K | 918.20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported